You are here: Industry Insights > Parkinson

News List

NIH partnership to improve clinical trials for Parkinson’s disease europeanpharmaceuticalreview
February 02, 2018
The NIH is teaming with the government, biopharmaceutical, life science and non-profit organisations to overcome obstacles and increase success for advancing promising treatments for PD…
New Study reveals correlation between protein levels in spinal fluid and gait difficulty in parkinso biospectrumasia
December 28, 2017
Study sponsored by The Michael J. Fox Foundation for Parkinson's Research found lower alpha-synuclein levels in spinal fluid associated with postural instability/gait difficulty phenotype.
Niclosamide could lead to new treatment for Parkinson’s disease europeanpharmaceuticalreview
December 14, 2017
Drug molecule in tapeworm medicine activates protein implicated in the development of Parkinson’s disease…
Acadia launches Parkinson’s campaign to shine light on psychosis symptoms fiercepharma
November 28, 2017
A new disease awareness campaign shines a light on the hallucinations and delusions that can affect half of people who have Parkinson’s disease.
Acorda drops experimental Parkinson’s drug pharmatimes
November 22, 2017
US biotech Acorda Therapeutics is discontinuing development of its experimental Parkinson’s disease therapy tozadenant on concerns over patient safety.
Acorda Takes a $363M Hit as Deaths Lead to Termination of Parkinson's Drug biospace
November 21, 2017
Acorda Therapeutics reported that it had ended enrollment in its Phase III clinical trial of tozadenant for Parkinson’s disease due to several patient deaths. Today, the company announced that it was discontinuing clinical development of the drug altogeth
Drugmaker Acorda suffers after deaths in Parkinson's Trial biospectrumasia
November 20, 2017
The company did not specify how many of the patients who died had agranulocytosis
5 Deaths Force Acorda to Stop Enrollment in Phase III Parkinson's Trial biospace
November 17, 2017
Acorda Therapeutics updated its Phase III clinical trial of tozadenant for Parkinson’s disease. Enrollment has been halted for new patients due to several deaths, and changes in the program have been made related to safety issues.
Parkinson’s disease drug carbidopa shows anticancer effects europeanpharmaceuticalreview
October 09, 2017
Research shows the Parkinson’s disease drug carbidopa displays significant anticancer effects in human cell lines…
Parkinson’s disease drug carbidopa shows anticancer effects europeanpharmaceuticalreview
September 30, 2017
Research shows the Parkinson’s disease drug carbidopa displays significant anticancer effects in human cell lines…

Previous page 1 2 3 4 5 6 7 8 9 Next page